CN Stock MarketDetailed Quotes

300485 Beijing Science Sun Pharmaceutical

Watchlist
  • 8.37
  • +0.10+1.21%
Market Closed Dec 12 15:00 CST
4.03BMarket Cap-21.03P/E (TTM)

Beijing Science Sun Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-46.27%108.35M
-67.26%71.2M
-38.48%126.24M
-46.88%120.16M
68.65%201.67M
91.18%217.46M
-10.64%205.2M
40.03%226.21M
-69.72%119.58M
-72.03%113.75M
Transactional financial assets
59.65%1.42B
33.61%1.14B
19.56%1.1B
17.65%1.05B
-23.15%890.08M
-24.97%854.63M
-12.13%921.14M
-21.08%895.39M
35.13%1.16B
47.15%1.14B
Notes receivable and accounts receivable
-17.46%56.19M
-16.70%56.59M
-33.41%52.91M
-38.16%52.42M
-30.52%68.08M
-21.98%67.93M
-11.30%79.46M
-11.88%84.76M
-4.44%97.98M
-27.30%87.07M
-Notes receivable
-25.30%4.62M
-41.01%3.94M
-57.00%4.4M
-37.76%5.46M
-27.89%6.19M
27.78%6.68M
115.14%10.23M
75.48%8.78M
1,048.58%8.58M
-65.84%5.23M
-Accounts receivable
-16.67%51.57M
-14.05%52.65M
-29.93%48.52M
-38.21%46.95M
-30.77%61.89M
-25.15%61.25M
-18.39%69.23M
-16.68%75.98M
-12.17%89.4M
-21.65%81.84M
Other receivables (including interest and dividends)
-72.99%1.14M
-68.20%1.32M
4.34%4.52M
-1.60%4.01M
180.57%4.22M
1.70%4.17M
-11.12%4.33M
315.67%4.08M
-2.69%1.5M
295.59%4.1M
-Other receivable
----
-68.20%1.32M
----
----
----
1.70%4.17M
----
315.67%4.08M
----
295.59%4.1M
Advance payment
10.03%5.07M
-23.51%3.44M
-97.53%115.25K
41.08%5.35M
297.62%4.61M
211.54%4.5M
74.70%4.66M
275.34%3.79M
-70.01%1.16M
51.84%1.44M
Inventories
-16.86%90.18M
-2.78%96.45M
11.29%108.46M
20.17%107.06M
27.03%108.47M
-0.96%99.22M
-11.25%97.46M
-27.60%89.09M
-38.36%85.39M
-34.62%100.17M
Other current assets
-7.83%7.48M
13.88%9.7M
-52.21%8.06M
-37.81%10.65M
1,018.07%8.12M
194.91%8.52M
72.15%16.86M
33.50%17.12M
-82.22%726.15K
-68.16%2.89M
Total current assets
31.45%1.69B
9.88%1.38B
5.45%1.4B
2.47%1.35B
-12.24%1.29B
-13.26%1.26B
-11.08%1.33B
-13.71%1.32B
-2.54%1.46B
-1.12%1.45B
Non Current assets
Other non-current financial assets
-65.62%256.03M
-30.63%545.82M
-14.06%482.98M
10.91%631.81M
29.98%744.74M
39.07%786.82M
23.05%561.97M
46.00%569.67M
138.28%572.96M
147.40%565.76M
Long-term equity investment
-13.64%719.91M
-18.50%727.61M
-14.28%702.52M
-3.22%802.91M
21.07%833.61M
29.01%892.82M
28.15%819.54M
33.38%829.62M
49.48%688.52M
47.87%692.08M
Fixed assets
----
-7.22%499.01M
----
----
----
-7.86%537.86M
----
5.99%559.46M
----
7.10%583.72M
Constru in process
----
183.87%1.37M
----
----
----
--482.24K
----
-99.54%327.52K
----
----
Productive biological assets
20.10%6.86M
2.45%5.95M
--6.15M
--5.53M
--5.71M
--5.81M
----
----
----
----
Intangible assets
-5.76%47.96M
-7.43%47.84M
-7.24%48.91M
-7.12%49.95M
-7.95%50.89M
-8.26%51.68M
-8.13%52.72M
-7.98%53.78M
8.51%55.28M
3.60%56.34M
Development expenditure
29.29%261.17M
27.47%247.95M
12.33%209.4M
13.53%208.97M
14.16%202M
17.64%194.51M
15.69%186.42M
16.12%184.07M
16.31%176.95M
8.71%165.34M
Goodwill
0.00%21.87M
0.00%21.87M
0.00%21.87M
0.00%21.87M
0.00%21.87M
0.00%21.87M
0.00%21.87M
0.00%21.87M
0.00%21.87M
0.00%21.87M
Long deferred expense
----
----
----
----
----
----
----
--0
----
----
Deferred tax assets
-55.69%2.34M
-56.24%2.35M
-44.81%2.52M
-54.52%2.42M
108.12%5.27M
112.89%5.38M
76.75%4.57M
111.61%5.33M
-8.73%2.53M
5.81%2.53M
Usufruct assets
-2.35%11.85M
-2.33%11.93M
-2.85%11.96M
-2.83%12.04M
--12.13M
--12.22M
--12.31M
--12.4M
----
----
Other non current assets
-2.40%11.21M
-1.37%11.4M
4.18%11.45M
-2.75%11.79M
-20.00%11.49M
4.56%11.56M
-80.50%10.99M
-36.23%12.12M
3.86%14.36M
-51.27%11.06M
Total non current assets
-24.42%1.83B
-15.78%2.12B
-9.50%2.01B
0.91%2.27B
14.85%2.42B
20.12%2.52B
11.99%2.22B
20.15%2.25B
36.15%2.11B
34.41%2.1B
Total assets
-5.03%3.52B
-7.25%3.5B
-3.90%3.41B
1.49%3.62B
3.74%3.7B
6.49%3.78B
2.07%3.55B
4.92%3.57B
17.09%3.57B
17.21%3.55B
Liabilities
Current liabilities
Notes payable and accounts payable
10.30%11.49M
-2.73%11.11M
-23.32%16.37M
-29.97%15.13M
-59.61%10.42M
-56.78%11.42M
26.01%21.35M
-21.21%21.61M
14.92%25.79M
-1.03%26.42M
-Accounts payable
10.30%11.49M
-2.73%11.11M
-23.32%16.37M
-29.97%15.13M
-59.61%10.42M
-56.78%11.42M
26.01%21.35M
-21.21%21.61M
14.92%25.79M
-1.03%26.42M
Contract liabilities
-0.86%6.42M
0.94%5.64M
-40.14%5.12M
-30.65%6.08M
-23.17%6.48M
-45.43%5.59M
-26.21%8.56M
-28.67%8.77M
10.64%8.43M
5.57%10.24M
Advance receipts
----
----
----
0.00%352.29K
----
----
----
28.00%352.29K
--0
----
Salaries payable
-14.18%4.54M
-17.25%4.55M
-14.60%4.92M
-8.65%4.76M
16.31%5.29M
23.42%5.5M
19.19%5.76M
-14.08%5.21M
-2.90%4.55M
-23.50%4.46M
Taxs payable
15.30%2.13M
-28.82%2.19M
-22.21%2.64M
-58.94%1.34M
-78.74%1.84M
-32.53%3.07M
-50.01%3.4M
-54.35%3.27M
-14.87%8.68M
-33.97%4.55M
Other payable (including interest and dividends)
326.43%57.69M
122.97%50.12M
143.52%37.42M
-33.52%22.99M
-5.05%13.53M
89.21%22.48M
180.48%15.37M
2.00%34.59M
-68.41%14.25M
-82.95%11.88M
-Other payable
----
122.97%50.12M
----
----
----
89.21%22.48M
----
2.00%34.59M
----
-82.95%11.88M
Non current liabilities due within one year
----
----
----
----
----
----
----
--0
----
----
Other current liabilities
-0.86%835.17K
0.94%733.21K
-40.14%665.87K
-30.65%790.65K
-23.17%842.46K
-45.43%726.36K
-26.21%1.11M
-14.26%1.14M
10.64%1.1M
5.57%1.33M
Total current liabilities
116.41%83.11M
52.38%74.33M
20.88%67.14M
-31.34%51.45M
-38.84%38.4M
-17.15%48.78M
17.79%55.54M
-15.29%74.94M
-31.02%62.8M
-50.96%58.88M
Current liabilities
Deferred tax liabilities
-20.44%80.25M
-25.05%80.37M
-16.46%67.81M
25.56%103.16M
96.50%100.87M
108.21%107.22M
99.68%81.16M
173.12%82.16M
613.50%51.33M
800.70%51.5M
Total non current liabilities
-20.44%80.25M
-25.05%80.37M
-16.46%67.81M
25.56%103.16M
96.50%100.87M
108.21%107.22M
99.68%81.16M
173.12%82.16M
613.50%51.33M
800.70%51.5M
Total liabilities
17.30%163.36M
-0.83%154.7M
-1.29%134.94M
-1.58%154.61M
22.03%139.27M
41.34%156M
55.70%136.7M
32.52%157.1M
16.18%114.13M
-12.25%110.38M
Shareholders equity
Paid-in capital
0.00%481.67M
0.00%481.67M
0.00%481.67M
0.00%481.67M
0.00%481.67M
0.00%481.67M
0.00%481.67M
0.00%481.67M
0.00%481.67M
0.00%481.67M
Capital reserve funds
0.00%845.93M
0.00%845.93M
0.00%845.93M
0.00%845.93M
0.28%845.93M
0.28%845.93M
0.28%845.93M
0.28%845.93M
0.63%843.56M
0.63%843.56M
Surplus reserve funds
0.00%244.68M
0.00%244.68M
0.00%244.68M
0.00%244.68M
9.74%244.68M
9.74%244.68M
9.74%244.68M
9.74%244.68M
27.53%222.96M
27.53%222.96M
Retained profit
-10.35%1.75B
-13.15%1.75B
-7.21%1.67B
3.42%1.86B
4.57%1.96B
8.59%2.01B
-0.20%1.8B
6.01%1.8B
31.95%1.87B
35.66%1.85B
Other composite income
-61.89%534.61K
-30.30%1.14M
803.34%978.73K
181.85%917.04K
40.38%1.4M
273.69%1.63M
94.95%-139.16K
112.43%325.37K
148.30%999.33K
57.17%-940.3K
Shareholders equity without minority interests
-5.76%3.33B
-7.39%3.32B
-3.82%3.25B
1.84%3.44B
3.22%3.53B
5.46%3.59B
0.69%3.37B
3.98%3.37B
17.50%3.42B
18.95%3.4B
Minority interests
-20.89%27.57M
-20.86%28.46M
-20.76%29.85M
-17.09%31.58M
-4.52%34.85M
-2.84%35.97M
0.07%37.67M
-0.74%38.09M
-10.43%36.5M
-12.45%37.02M
Total shareholder equity
-5.91%3.35B
-7.52%3.35B
-4.00%3.28B
1.63%3.47B
3.13%3.56B
5.37%3.62B
0.68%3.41B
3.93%3.41B
17.12%3.46B
18.49%3.44B
Total liabilityies and equity
-5.03%3.52B
-7.25%3.5B
-3.90%3.41B
1.49%3.62B
3.74%3.7B
6.49%3.78B
2.07%3.55B
4.92%3.57B
17.09%3.57B
17.21%3.55B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Grant Thornton Certified Public Accountants (Special General Partnership)
--
--
--
Grant Thornton Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -46.27%108.35M-67.26%71.2M-38.48%126.24M-46.88%120.16M68.65%201.67M91.18%217.46M-10.64%205.2M40.03%226.21M-69.72%119.58M-72.03%113.75M
Transactional financial assets 59.65%1.42B33.61%1.14B19.56%1.1B17.65%1.05B-23.15%890.08M-24.97%854.63M-12.13%921.14M-21.08%895.39M35.13%1.16B47.15%1.14B
Notes receivable and accounts receivable -17.46%56.19M-16.70%56.59M-33.41%52.91M-38.16%52.42M-30.52%68.08M-21.98%67.93M-11.30%79.46M-11.88%84.76M-4.44%97.98M-27.30%87.07M
-Notes receivable -25.30%4.62M-41.01%3.94M-57.00%4.4M-37.76%5.46M-27.89%6.19M27.78%6.68M115.14%10.23M75.48%8.78M1,048.58%8.58M-65.84%5.23M
-Accounts receivable -16.67%51.57M-14.05%52.65M-29.93%48.52M-38.21%46.95M-30.77%61.89M-25.15%61.25M-18.39%69.23M-16.68%75.98M-12.17%89.4M-21.65%81.84M
Other receivables (including interest and dividends) -72.99%1.14M-68.20%1.32M4.34%4.52M-1.60%4.01M180.57%4.22M1.70%4.17M-11.12%4.33M315.67%4.08M-2.69%1.5M295.59%4.1M
-Other receivable -----68.20%1.32M------------1.70%4.17M----315.67%4.08M----295.59%4.1M
Advance payment 10.03%5.07M-23.51%3.44M-97.53%115.25K41.08%5.35M297.62%4.61M211.54%4.5M74.70%4.66M275.34%3.79M-70.01%1.16M51.84%1.44M
Inventories -16.86%90.18M-2.78%96.45M11.29%108.46M20.17%107.06M27.03%108.47M-0.96%99.22M-11.25%97.46M-27.60%89.09M-38.36%85.39M-34.62%100.17M
Other current assets -7.83%7.48M13.88%9.7M-52.21%8.06M-37.81%10.65M1,018.07%8.12M194.91%8.52M72.15%16.86M33.50%17.12M-82.22%726.15K-68.16%2.89M
Total current assets 31.45%1.69B9.88%1.38B5.45%1.4B2.47%1.35B-12.24%1.29B-13.26%1.26B-11.08%1.33B-13.71%1.32B-2.54%1.46B-1.12%1.45B
Non Current assets
Other non-current financial assets -65.62%256.03M-30.63%545.82M-14.06%482.98M10.91%631.81M29.98%744.74M39.07%786.82M23.05%561.97M46.00%569.67M138.28%572.96M147.40%565.76M
Long-term equity investment -13.64%719.91M-18.50%727.61M-14.28%702.52M-3.22%802.91M21.07%833.61M29.01%892.82M28.15%819.54M33.38%829.62M49.48%688.52M47.87%692.08M
Fixed assets -----7.22%499.01M-------------7.86%537.86M----5.99%559.46M----7.10%583.72M
Constru in process ----183.87%1.37M--------------482.24K-----99.54%327.52K--------
Productive biological assets 20.10%6.86M2.45%5.95M--6.15M--5.53M--5.71M--5.81M----------------
Intangible assets -5.76%47.96M-7.43%47.84M-7.24%48.91M-7.12%49.95M-7.95%50.89M-8.26%51.68M-8.13%52.72M-7.98%53.78M8.51%55.28M3.60%56.34M
Development expenditure 29.29%261.17M27.47%247.95M12.33%209.4M13.53%208.97M14.16%202M17.64%194.51M15.69%186.42M16.12%184.07M16.31%176.95M8.71%165.34M
Goodwill 0.00%21.87M0.00%21.87M0.00%21.87M0.00%21.87M0.00%21.87M0.00%21.87M0.00%21.87M0.00%21.87M0.00%21.87M0.00%21.87M
Long deferred expense ------------------------------0--------
Deferred tax assets -55.69%2.34M-56.24%2.35M-44.81%2.52M-54.52%2.42M108.12%5.27M112.89%5.38M76.75%4.57M111.61%5.33M-8.73%2.53M5.81%2.53M
Usufruct assets -2.35%11.85M-2.33%11.93M-2.85%11.96M-2.83%12.04M--12.13M--12.22M--12.31M--12.4M--------
Other non current assets -2.40%11.21M-1.37%11.4M4.18%11.45M-2.75%11.79M-20.00%11.49M4.56%11.56M-80.50%10.99M-36.23%12.12M3.86%14.36M-51.27%11.06M
Total non current assets -24.42%1.83B-15.78%2.12B-9.50%2.01B0.91%2.27B14.85%2.42B20.12%2.52B11.99%2.22B20.15%2.25B36.15%2.11B34.41%2.1B
Total assets -5.03%3.52B-7.25%3.5B-3.90%3.41B1.49%3.62B3.74%3.7B6.49%3.78B2.07%3.55B4.92%3.57B17.09%3.57B17.21%3.55B
Liabilities
Current liabilities
Notes payable and accounts payable 10.30%11.49M-2.73%11.11M-23.32%16.37M-29.97%15.13M-59.61%10.42M-56.78%11.42M26.01%21.35M-21.21%21.61M14.92%25.79M-1.03%26.42M
-Accounts payable 10.30%11.49M-2.73%11.11M-23.32%16.37M-29.97%15.13M-59.61%10.42M-56.78%11.42M26.01%21.35M-21.21%21.61M14.92%25.79M-1.03%26.42M
Contract liabilities -0.86%6.42M0.94%5.64M-40.14%5.12M-30.65%6.08M-23.17%6.48M-45.43%5.59M-26.21%8.56M-28.67%8.77M10.64%8.43M5.57%10.24M
Advance receipts ------------0.00%352.29K------------28.00%352.29K--0----
Salaries payable -14.18%4.54M-17.25%4.55M-14.60%4.92M-8.65%4.76M16.31%5.29M23.42%5.5M19.19%5.76M-14.08%5.21M-2.90%4.55M-23.50%4.46M
Taxs payable 15.30%2.13M-28.82%2.19M-22.21%2.64M-58.94%1.34M-78.74%1.84M-32.53%3.07M-50.01%3.4M-54.35%3.27M-14.87%8.68M-33.97%4.55M
Other payable (including interest and dividends) 326.43%57.69M122.97%50.12M143.52%37.42M-33.52%22.99M-5.05%13.53M89.21%22.48M180.48%15.37M2.00%34.59M-68.41%14.25M-82.95%11.88M
-Other payable ----122.97%50.12M------------89.21%22.48M----2.00%34.59M-----82.95%11.88M
Non current liabilities due within one year ------------------------------0--------
Other current liabilities -0.86%835.17K0.94%733.21K-40.14%665.87K-30.65%790.65K-23.17%842.46K-45.43%726.36K-26.21%1.11M-14.26%1.14M10.64%1.1M5.57%1.33M
Total current liabilities 116.41%83.11M52.38%74.33M20.88%67.14M-31.34%51.45M-38.84%38.4M-17.15%48.78M17.79%55.54M-15.29%74.94M-31.02%62.8M-50.96%58.88M
Current liabilities
Deferred tax liabilities -20.44%80.25M-25.05%80.37M-16.46%67.81M25.56%103.16M96.50%100.87M108.21%107.22M99.68%81.16M173.12%82.16M613.50%51.33M800.70%51.5M
Total non current liabilities -20.44%80.25M-25.05%80.37M-16.46%67.81M25.56%103.16M96.50%100.87M108.21%107.22M99.68%81.16M173.12%82.16M613.50%51.33M800.70%51.5M
Total liabilities 17.30%163.36M-0.83%154.7M-1.29%134.94M-1.58%154.61M22.03%139.27M41.34%156M55.70%136.7M32.52%157.1M16.18%114.13M-12.25%110.38M
Shareholders equity
Paid-in capital 0.00%481.67M0.00%481.67M0.00%481.67M0.00%481.67M0.00%481.67M0.00%481.67M0.00%481.67M0.00%481.67M0.00%481.67M0.00%481.67M
Capital reserve funds 0.00%845.93M0.00%845.93M0.00%845.93M0.00%845.93M0.28%845.93M0.28%845.93M0.28%845.93M0.28%845.93M0.63%843.56M0.63%843.56M
Surplus reserve funds 0.00%244.68M0.00%244.68M0.00%244.68M0.00%244.68M9.74%244.68M9.74%244.68M9.74%244.68M9.74%244.68M27.53%222.96M27.53%222.96M
Retained profit -10.35%1.75B-13.15%1.75B-7.21%1.67B3.42%1.86B4.57%1.96B8.59%2.01B-0.20%1.8B6.01%1.8B31.95%1.87B35.66%1.85B
Other composite income -61.89%534.61K-30.30%1.14M803.34%978.73K181.85%917.04K40.38%1.4M273.69%1.63M94.95%-139.16K112.43%325.37K148.30%999.33K57.17%-940.3K
Shareholders equity without minority interests -5.76%3.33B-7.39%3.32B-3.82%3.25B1.84%3.44B3.22%3.53B5.46%3.59B0.69%3.37B3.98%3.37B17.50%3.42B18.95%3.4B
Minority interests -20.89%27.57M-20.86%28.46M-20.76%29.85M-17.09%31.58M-4.52%34.85M-2.84%35.97M0.07%37.67M-0.74%38.09M-10.43%36.5M-12.45%37.02M
Total shareholder equity -5.91%3.35B-7.52%3.35B-4.00%3.28B1.63%3.47B3.13%3.56B5.37%3.62B0.68%3.41B3.93%3.41B17.12%3.46B18.49%3.44B
Total liabilityies and equity -5.03%3.52B-7.25%3.5B-3.90%3.41B1.49%3.62B3.74%3.7B6.49%3.78B2.07%3.55B4.92%3.57B17.09%3.57B17.21%3.55B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Grant Thornton Certified Public Accountants (Special General Partnership)------Grant Thornton Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data